Incidence of adverse drug reactions in hospitalized patients: A meta- analysis of prospective studies

Journal of the American Medical Association

Volumn 279, Issue 15, 1998, Pages 1200-1205

  Lazarou, Jason ^a   Pomeranz, Bruce H ^a,b   Corey, Paul N ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; HOSPITAL PATIENT; HOSPITALIZATION; INCIDENCE; PRIORITY JOURNAL; REVIEW;

DATA COLLECTION; DRUG THERAPY; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; IATROGENIC DISEASE; INCIDENCE; INPATIENTS; LINEAR MODELS; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0032522873     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.15.1200     Document Type: Review

References (59)

1. Gray J. Bill would force drug makers to give customers data on risks. New York Times. July 25, 1996: A11.
2. D'Arcy PF, Griffin JP. Thalidomide revisited. Adverse Drug React Toxicol Rev. 1994;13:65-76.
3. Cluff LE, Thornton CF, Seidl LG. Studies on the epidemiology of adverse drug reactions, part 1: methods of surveillance. JAMA. 1964;188:976-983.
4. Seidl LG, Thornton GF, Smith JW, Cluff LE. Studies on the epidemiology of adverse drug reactions, III: reactions in patients on a general medical service. Johns Hopkins Hosp Bull. 1966;119:299-315.
5. Borda IT, Slone D, Jick H. Assessment of adverse reactions within a drug surveillance program. JAMA. 1968;205:99-101.
6. Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974;134:219-223.
7. Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions, V: clinical factors influencing susceptibility. Ann Intern Med. 1966;65:629-640.
8. World Health Organization. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: World Health Organization; 1966. Technical Report Series No. 425.
9. Bates DB, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993;8:289-294.
10. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975;234:1236-1241.
11. Chalmers TC, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
12. Karch FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasagna L. Adverse drug reactions - a matter of opinion. Int J Clin Pharmacol Ther. 1976;19:489-92.
13. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol. 1995;142: 371-382.
14. DerSimonian L, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for metaanalysis. Stat Med. 1995;14:395-411.
16. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27:832-840.
17. Rosner B. Fundamentals of Biostatistics. 4th ed. New York, NY: Duxbury Press; 1995.
18. Morgan K, Morgan S, Quitno N. Health Care State Rankings 1996. 4th ed. Lawrence, Kan: Morgan Quitno Press; 1996.
19. Bates DW, Boyle DL, Vander Vliet MB, Scheider J, Leape LL. Relationship between medication errors and adverse drug reactions. J Gen Intern Med. 1995;10:199-205.
20. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
21. Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm. 1994;47:209-216.
22. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med. 1981;304:638-642.
23. Mitchell AA, Goldman P, Shapiro S, Slone S. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol. 1979;110: 196-204.
24. Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm. 1977;34:931-936.
25. May FE, Fuller S, Stewart RB. Drug use and adverse drug reactions prior to and during hospitalization. J Am Pharm Assoc. 1977;17:560-598.
26. Miller RR. Drug surveillance utilizing epidemiological methods: a report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm. 1973;30:584-592.
27. McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm. 1973;30:898-903.
28. Wang R, Terry LC. Adverse drug reactions in a Veterans Administration hospital. J Clin Pharmacol New Drugs. 1971;11:14-18.
29. Gardner P, Watson LJ. Adverse drugreactions: a pharmacist-based monitoring system. J Clin Pharm Ther. 1970;11:802-807.
30. Sidel VW, Koch-Weser J, Barnett GO, Eaton A. Drug utilization and adverse reactions in a general hospital. Hospitals. 1967;41:80-88.
31. Reichel W. Complications in the care of five hundred elderly hospitalized patients. J Am Geriatr Soc. 1965;13:973-977.
32. Schimmel EM. The hazards of hospitalization. Ann Intern Med. 1964;60:100-110.
33. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701-707.
34. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841-845.
35. Mitchell AA, Lacouture PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics. 1988; 82:24-29.
36. Bigby J, Dunn J, Goldman L, et al. Assessing the preventability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care facility. Am J Med. 1987;83:1031-1036.
37. Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med. 1986;146:1931-1934.
38. Salem RB, Keane TM, Williams JG. Drug-related admissions to a Veterans' Administration psychiatric unit. Drug Intell Clin Pharm. 1984;18: 74-76.
39. Stewart RB, Springer PK, Adams JE. Drug-related admissions to an inpatient psychiatric unit. Am J Psychiatry. 1980;137:1093-1095.
40. Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon patient admission to small hospitals. Am J Hosp Pharm. 1977;34:738-742.
41. McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm. 1976;33:792-795.
42. McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr. 1976;89:487-490.
43. Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA. 1974;228:713-717.
44. Rawlins M, Thompson J. Mechanisms of adverse drug reactions. In: Davies D, ed. Textbook of Adverse Drug Reactions. 4th ed. Oxford, England: Oxford University Press; 1991.
45. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc. 1991;39:1093-1099.
46. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ. 1969;1: 531-536.
47. Ogilvie RI, Ruedy J. Adverse drug reactions during hospitalization. Can Med Assoc J. 1967;97: 1450-1457.
48. Domecq C, Naranjo CA, Ruiz I, Busto U. Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol. 1980;18:362-366.
49. Zilleruelo I, Espinoza E, Ruiz I. Influence of the assessment of the severity on the frequency of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol. 1987;25:328-333.
50. National Center for Health Statistics. National Hospital Discharge Survey: Annual Summary, 1992. Hyattsville, Md: US Dept of Health and Human Services; 1994. Publication 94-1779.
51. Kahn L, Rubenstein L, Draper D, et al. The effects of the DRG-based prospective payment system on quality of care for hospitalized medicare patients. JAMA. 1990;264:1953-1955.
52. Hurwitz N. Predisposing factors in adverse drug reactions to drugs. BMJ. 1969;1:536-539.
53. Smidt NA, McQueen EG. Adverse reactions to drugs: a comprehensive hospital inpatient survey. N Z Med J. 1972;76:397-401.
54. Smidt NA, McQueen EG. Adverse drug reactions in a general hospital. N Z Med J. 1973;78:39.
55. O'Hara D, Carson N. Reporting of adverse events in hospitals in Victoria, 1994-1995. Med J Aust. 1997;166:460-463.
56. Evans RC, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-527.
57. Classen DC, Pestonik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
58. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307-311.
59. American Hospital Association. Hospital Statistics, 1993-1994. Chicago, Ill: American Hospital Association; 1994.